Assistant Professor, Medicine, University of Minnesota Medical School
Oncology
Dr. Anne H. Blaes, MD
|
|
Give Review
Anne H. Blaes works in the field of Oncology. He went to medical school at Loyola University Chicago Stritch School of Medicine. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Anne H. Blaes, MD is also a published MD. He has 24 paper published. The most recent paper is: Cardiovascular Complications of Hematopoietic Stem Cell Transplantation. Dr. Anne H. Blaes is registered with Medicare.
Publications
- Cardiovascular Complications of Hematopoietic Stem Cell Transplantation.
- A phase I feasibility study of multi-modality imaging assessing rapid expansion of marrow fat and decreased bone mineral density in Cancer patients.
- Hematopoietic Stem Cell Transplantation in Patients with Systolic Dysfunction: Can it be Done?
- Burkitt Lymphoma in Pregnancy: Two Cases of Successful Treatment and Continued Fertility; With a Review of the Literature.
- Prophylactic Mastectomy: A Treatment Alternative for Hodgkin Survivors?
- Effectiveness of treatment summaries in increasing breast and coloRectal cancer survivors' knowledge about their diagnosis and treatment.
- Patient Satisfaction with Physician Discussions of Treatment Impact on Fertility, Menopause and Sexual Health among Pre-menopausal Women with Cancer.
- Quality of life appears similar between survivors of indolent and aggressive non-Hodgkin Lymphoma.
- Breast and coloRectal cancer survivors' knowledge about their diagnosis and treatment.
- Nonpharmacologic complementary therapies in symptom management for breast Cancer survivors.
- Pathologic femur fractures after limb-sparing treatment of soft-tissue Sarcomas.
- Cardiac complications from Cancer therapy.
- Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cor...
- Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial.
- Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast Cancer treatment.
- Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic Cell transplant recipients.
- Malassezia: is it a pulmonary pathogen in the stem Cell transplant population?
- Post-transplant lymphoproliferative disorders in Lung transplant recipients: 20-yr experience at the University of Minnesota.
- Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders.
- Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic Cell transplantation.
- Angiotensin converting enzyme inhibitors may be protective against cardiac complications following anthracycline chemotherapy.
- Necrotizing leukoencephalopathy following CHOP chemotherapy.
- Post-transplant lymphoproliferative disorders following solid-organ transplantation.
Schools
Loyola University Of ChicagoStritch School Of Medicine
University Minn Med School
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Choice Plus POS II
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tricare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Minnesota -
Loyola University Chicago Stritch School of Medicine
Hospital
-
University of Minnesota Medical Center, Fairview
Drug Facts
| NPI NUMBER | 1285690156 | |
| NPPES Provider LastName | BLAES | |
| NPPES Provider FirstName | ANNE | |
| NPPES Provider ZIPCode | 554550341 | |
| NPPES Provider State | MN | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 394.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1285690156 |
| Last Name Of The Provider | BLAES |
| First Name Of The Provider | ANNE |
| View All |
Similar Doctors
|
|
Dr. Dean H. Gesme, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick J. Flynn, MD |
|
|
Dr. Heather C. Beckwith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. R David Dexter, MD |
|
|
Dr. Rajini K. Malisetti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katharine S. Park, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Venkatesh K. Rudrapatna, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Punit D. Wadhwa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michaela L. Tsai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andres R. Wiernik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dylan M. Zylla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yvonne H. Datta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wesley J. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karamjeet S. Sandhu, MD |